SCHEMBL29756239

SCHEMBL29756239

COC(=O)c1nc(N)c(Br)cc1F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.42
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 10/20 0.38
ALDH1A1 P00352 8/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
HSD17B10 Q99714 2/20 0.38
CGAS Q8N884 1/20 0.37
ILK Q13418 1/20 0.37
HPGD P15428 3/20 0.36
NOTUM Q6P988 1/20 0.36
SOS1 Q07889 1/20 0.35
RAB9A P51151 1/20 0.35
PKM P14618 3/20 0.35
RCE1 Q9Y256 1/20 0.35
ATM Q13315 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CFTR P13569 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3243373 1.00 NPSR1 (0.42) NPSR1LMNATSHRKDM4EALDH1A1
SCHEMBL30317190 0.87 NPSR1 (0.42) NPSR1LMNATSHRKDM4EALDH1A1
SCHEMBL2013864 0.85 NPSR1 (0.47) NPSR1TSHRKDM4EALDH1A1SMN1; SMN2
SCHEMBL14475982 0.85 NPSR1 (0.47) NPSR1LMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL2257139 0.82 NPSR1 (0.44) NPSR1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL29756168 0.82 NPSR1 (0.44) NPSR1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL3247954 0.81 KDM4E (0.44) NPSR1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL19028097 0.81 NPSR1 (0.42) NPSR1LMNATSHRKDM4EALDH1A1
SCHEMBL27388974 0.75 NPSR1 (0.44) NPSR1LMNATSHRKDM4EALDH1A1
SCHEMBL318846 0.74 CFTR (0.44) NPSR1KDM4EALDH1A1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4293029-B1 AZAHETEROARYL COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF SHANGHAI BLUERAY BIOPHARMA CO LTD (CN) 2025-12-17 EP disclosed
US-20240182492-A1 AZAHETEROARYL COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) 2024-06-06 US disclosed
EP-4293029-A1 AZAHETEROARYL COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shanghai Blueray Biopharma Co., Ltd. (CN) 2023-12-20 EP disclosed
WO-2022171166-A1 AZAHETEROARYL COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 上海青煜医药科技有限公司 2022-08-18 WO disclosed
CN-114907385-A Nitrogen heteroaryl compound, preparation method and application thereof 上海青煜医药科技有限公司 2022-08-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240182492-A1 AZAHETEROARYL COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF EZH2, EED, EZH1 NPSR1 3315/4885LMNA 4183/4885TSHR 4477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.